Tag Archives: fibrotic liver diseases

Boehringer Ingelheim and MiNA Therapeutics partner on the development of novel compounds to treat fibrotic liver diseases

Collaboration and licensing agreement focused on investigating up to three targets and has a potential transactional value of up to EUR 307 million, excluding royalties Expands Boehringer Ingelheim’s comprehensive R&D programme in non-alcoholic steatohepatitis (NASH) and fibrotic liver disease with … Read the full press release